Why Q32 Bio Stock Skyrocketed Today
Shares of Q32 Bio (NASDAQ: QTTB) soared on Monday after the biotechnology company announced promising clinical trial results for its experimental hair loss treatment.
Image source: Getty Images.
A Phase 2a clinical study of Q32 Bio's investigational antibody treatment, bempikibart, in patients with severe or very severe alopecia areata met its primary efficacy goal.
Source Fool.com


